Bank Of Marin Catalent, Inc. Transaction History

Bank Of Marin

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$32.18 - $46.57 $17,988 - $26,032	559 Added 11.06%	5,615 $252,000
Q3 2023 Nov 07, 2023	BUY	$44.2 - $50.2 $223,475 - $253,811	5,056 New	5,056 $230,000
Q1 2023 May 05, 2023	SELL	$45.44 - $74.26 $203,707 - $332,907	-4,483 Reduced 45.57%	5,354 $351,000
Q4 2022 Feb 13, 2023	BUY	$41.39 - $81.0 $113,408 - $221,940	2,740 Added 38.61%	9,837 $442,000
Q3 2022 Nov 09, 2022	BUY	$72.36 - $113.1 $74,820 - $116,945	1,034 Added 17.05%	7,097 $514,000
Q2 2022 Aug 16, 2022	BUY	$87.2 - $114.05 $162,366 - $212,361	1,862 Added 44.32%	6,063 $650,000
Q4 2021 Feb 15, 2022	SELL	$119.57 - $139.07 $97,090 - $112,924	-812 Reduced 16.2%	4,201 $538,000
Q3 2021 Nov 15, 2021	SELL	$109.17 - $142.35 $317,575 - $414,096	-2,909 Reduced 36.72%	5,013 $667,000
Q2 2021 Aug 09, 2021	BUY	$100.34 - $115.69 $129,137 - $148,893	1,287 Added 19.4%	7,922 $857,000
Q1 2021 May 04, 2021	BUY	$101.51 - $125.27 $30,859 - $38,082	304 Added 4.8%	6,635 $699,000
Q4 2020 Feb 10, 2021	BUY	$85.88 - $105.36 $4,981 - $6,110	58 Added 0.92%	6,331 $659,000
Q1 2020 May 13, 2020	BUY	$36.95 - $62.95 $231,787 - $394,885	6,273 New	6,273 $326,000

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Bank Of Marin, based on Form 13F filings with the SEC.

Stay updated on Bank Of Marin with notifications on news.